Biocon Ltd : Press Statement on President Marketing's Move

Biocon, Asia's leading biotechnology company, announced today that Rakesh Bamzai, President - Marketing, has decided to leave the organization and accept a new leadership role.

"In his 19 years with the company, Rakesh has played a pivotal role in Biocon's evolution from a leading enzymes company to a global biopharmaceutical enterprise of great repute. As part of the core management of the company, Rakesh was instrumental in creating Biocon's global footprint and building a team of capable individuals to take up higher challenges in the organization.

Rakesh has decided to take up a very senior and challenging leadership assignment and we wish him the best for the future. While his presence will be missed, we firmly believe that he will continue to be a strong brand ambassador for the company going forward," said Ms Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon.

Rakesh Bamzai said: "I have immensely enjoyed my time at Biocon, which has been my home for nearly two decades. I have no doubt that I will remain engaged with Biocon in the future. I am confident that the team I leave behind will ensure Biocon's continued success."

About Biocon
Established in 1978, Biocon Limited, (BSE code: 532523, NSE Id: BIOCON, ISIN Id: INE376G01013) is India's largest and Asia's leading biotechnology company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patients worldwide. Biocon's robust product portfolio includes the world's first Pichia-based recombinant human Insulin, INSUGEN(R), Glargine, BASALOG(R) and India's first biologic BioMAb-EGFR(TM) for head and neck cancer. It has now successfully developed its second novel biologic Itolizumab, a 'first in class' anti-CD6 monoclonal antibody, introduced as Alzumab(TM) for psoriasis in India, in 2013. For additional information please visit: www.biocon.

For further information:

Media Contacts:

Seema Ahuja
Head-Corporate Communications
Biocon Limited
T: [phone], M:[phone]
Email: [e-mail]

Rumman Ahmed
Biocon Limited
T: [phone], M:[phone]
Email: [e-mail]